Karyopharm Therapeutics (KPTI) EPS (Diluted) (2020 - 2026)
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) EPS (Diluted) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.02 Bn | 620.27 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 445.75 Bn | 439.18 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 357.52 Bn | 350.38 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 267.31 Bn | 259.62 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 156.58 Bn | 144.88 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.14 Bn | 44.75 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 43.04 Bn | 43.04 Bn | - | -3.06 |
| 8 | Incyte | 24.61 Bn | 20.07 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.30 Bn | 18.64 Bn | 683.80 Mn | 7.27 |
| 10 | Karyopharm Therapeutics | 46.59 Mn | -18.51 Mn | 32.35 Mn | -2.32 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.32 |
| Dec 31, 2025 | -5.58 |
| Sep 30, 2025 | -3.82 |
| Jun 30, 2025 | -4.32 |
| Mar 31, 2025 | -2.77 |
| Dec 31, 2024 | -3.65 |
| Sep 30, 2024 | -3.85 |
| Jun 30, 2024 | 2.31 |
| Mar 31, 2024 | -4.85 |
| Dec 31, 2023 | -5.53 |
| Sep 30, 2023 | -4.52 |
| Jun 30, 2023 | -4.29 |
| Mar 31, 2023 | -4.51 |
| Dec 31, 2022 | -7.22 |
| Sep 30, 2022 | -6.79 |
| Jun 30, 2022 | -9.24 |
| Mar 31, 2022 | -8.01 |
| Dec 31, 2021 | 7.71 |
| Sep 30, 2021 | -10.30 |
| Jun 30, 2021 | -10.69 |